This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Asceneuron Sa. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Robert Hett
Introduction
Robert Hett is a notable inventor based in Muttenz, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on piperazine derivatives. His research focuses on developing compounds that can serve as effective glycosidase inhibitors.
Latest Patents
Robert Hett holds a patent for "Succinate and fumarate acid addition salts of piperazine derivatives." This invention relates to the creation of succinic acid and fumaric acid addition salts of piperazine derivatives, which are valuable as pharmaceutical ingredients. The solid forms, including polymorphic variations, enhance the utility of these compounds in medical applications.
Career Highlights
Hett's career is marked by his role at Asceneuron SA, a company dedicated to advancing therapeutic solutions. His work has positioned him as a key figure in the development of new pharmaceutical agents that target specific biological pathways.
Collaborations
Robert collaborates with talented professionals such as Anna Quattropani and Santosh Shripad Kulkarni. Their combined expertise contributes to the innovative projects at Asceneuron SA.
Conclusion
Robert Hett's contributions to pharmaceutical innovation through his patent on piperazine derivatives highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile